Health Canada approves first monoclonal antibody for migraine preventionOnce-monthly subcutaneous injection can be self-administered by autoinjector MS patients had higher incidence of certain conditions: study of four provincesResearchers examined the health records of 14,000 MS patients in B.C., Saskatchewan, Manitoba and Nova Scotia between 1984 and 2014 Gabapentin and pregabalin ineffective for chronic low back pain Systematic review and meta-analysis identifies no benefit and increased risk of harm Deep-brain stimulation may help some patients with mild Alzheimer’s Stroke affects women more severely than men; more die, fewer recover fully One-third more women die from having a stroke than do their male counterparts, and women are 60% less likely to regain their independence afterwards New centre plans to improve understanding of neural diseases Can early exposure to anti-TNF therapy reduce the risk of Parkinson disease? Study suggests reducing systemic inflammation in patients with inflammatory bowel disease can also decrease the incidence of Parkinson disease Can the healthy brain offer clues to curing Alzheimer's? Management of migraine in children and adolescents Many therapies effective in adults have not been adequately studied in children. Ocrevus receives conditional approval for use in early primary progressive MS Intravenous monoclonal antibody originally approved only for use in relapsing remitting multiple sclerosis (MS) First Previous 19 20 21 22 23 Next Last